Abbott Laboratories delivered positive news, notably announcing a 7% dividend increase, raising its quarterly payout to $0.63. This move, highlighted earlier in December, reinforces its 'Dividend King' status and management's confidence in future performance. On December 30, a law firm alert concerning Abbott's significant $21 billion Exact Sciences acquisition was reportedly withdrawn, potentially streamlining the deal’s path to a Q2 2026 close. ABT closed at $125.78 on December 30, amidst a day where major market indices saw modest declines.